Key result
Transgenic overexpression of human adiponectin in mice increased circulating exosomes by approximately 1.5-fold but did not significantly improve glucose metabolism or triglyceride clearance.
Why the study?
It remained unclear whether and how adiponectin-mediated promotion of exosome production in vivo benefits glucose and lipid metabolism.
Does transgenic overexpression of human adiponectin increase plasma exosomes and improve glucose and lipid metabolism in mice?
Does transgenic overexpression of human adiponectin increase plasma exosomes and improve glucose and lipid metabolism in mice?
Chronic hyperadiponectinemia increases plasma exosomes in vivo but does not translate to significant improvements in glucose or lipid metabolism under metabolic stress in mice.
Answers are grounded in this paper and cite their sources.
Adiponectin overexpression fails to improve metabolism despite raising exosomes in mice; leaves open therapeutic relevance in humans.
The fat-derived factor, adiponectin, is considered a salutary circulating factor. We recently demonstrated that native adiponectin binds T-cadherin and promotes intracellular biogenesis and secretion of the exosome. Exosomes play important roles in various aspects of homeostasis, including glucose and energy metabolism. However, it remains unclear whether and how the promotion of exosome production by adiponectin in vivo is beneficial for glucose and lipid metabolism. In the present study, overexpression of human adiponectin in mice resulted in an increased number of circulating exosomes, but it did not significantly improve glucose metabolism, change body weights, or change triglyceride clearance under a high-fat diet. Multiple small doses of streptozotocin increased blood glucose and decreased triglyceride clearance similarly in both wild-type and transgenic mice. Thus, these results indicated that human adiponectin overexpression in mice increases plasma exosomes but does not significantly influence glucose and lipid metabolism.
No takes yet. Share an insight, caveat, or question.
Kawada et al. (2023) studied Glucose and lipid metabolism. Transgenic overexpression of human adiponectin vs. Wild-type littermates was evaluated on Plasma exosome levels and glucose/lipid metabolism. Transgenic overexpression of human adiponectin in mice increased circulating exosomes by approximately 1.5-fold but did not significantly improve glucose metabolism or triglyceride clearance.
Synapse has enriched 10 related papers. Consider them for comparative context: